Morgan Stanley’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$105M Buy
4,491,067
+2,962,591
+194% +$53.6M 0.01% 1401
2025
Q4
$21.7M Sell
1,528,476
-218,766
-13% -$4.14M ﹤0.01% 2867
2025
Q3
$43.3M Sell
1,747,242
-551,593
-24% -$12.3M ﹤0.01% 2131
2025
Q2
$52.2M Buy
2,298,835
+1,442,051
+168% +$34.2M ﹤0.01% 1892
2025
Q1
$26M Buy
856,784
+75,389
+10% +$2.87M ﹤0.01% 2432
2024
Q4
$31M Buy
781,395
+343,143
+78% +$15.5M ﹤0.01% 2306
2024
Q3
$27.8M Sell
438,252
-141,656
-24% -$10.2M ﹤0.01% 2461
2024
Q2
$39.2M Sell
579,908
-88,409
-13% -$6.17M ﹤0.01% 1977
2024
Q1
$52.9M Sell
668,317
-334,223
-33% -$27.3M ﹤0.01% 1704
2023
Q4
$78M Buy
1,002,540
+430,242
+75% +$31.8M ﹤0.01% 1987
2023
Q3
$40.2M Sell
572,298
-147,812
-21% -$11M ﹤0.01% 1786
2023
Q2
$57.3M Buy
720,110
+114,515
+19% +$8.28M 0.01% 1469
2023
Q1
$43.8M Sell
605,595
-41,964
-6% -$3.27M ﹤0.01% 1666
2022
Q4
$53.3M Buy
647,559
+32,223
+5% +$2.66M 0.01% 1445
2022
Q3
$48.1M Buy
615,336
+194,289
+46% +$15.5M 0.01% 1339
2022
Q2
$28.5M Buy
421,047
+269,478
+178% +$18.8M ﹤0.01% 1898
2022
Q1
$9.93M Buy
151,569
+29,189
+24% +$1.7M ﹤0.01% 2914
2021
Q4
$7.43M Sell
122,380
-66,676
-35% -$3.98M ﹤0.01% 3294
2021
Q3
$12.1M Sell
189,056
-7,024
-4% -$443K ﹤0.01% 2672
2021
Q2
$12.3M Buy
196,080
+140,231
+251% +$8.79M ﹤0.01% 2750
2021
Q1
$3.19M Sell
55,849
-48,079
-46% -$2.6M ﹤0.01% 3867
2020
Q4
$5.22M Buy
103,928
+39,387
+61% +$1.57M ﹤0.01% 3214
2020
Q3
$1.9M Sell
64,541
-7,048
-10% -$205K ﹤0.01% 3694
2020
Q2
$1.8M Buy
71,589
+44,810
+167% +$1.12M ﹤0.01% 3687
2020
Q1
$492K Sell
26,779
-44,433
-62% -$1.27M ﹤0.01% 4379
2019
Q4
$2.37M Buy
71,212
+43,336
+155% +$1.36M ﹤0.01% 3904
2019
Q3
$867K Sell
27,876
-10,865
-28% -$331K ﹤0.01% 4377
2019
Q2
$1.35M Buy
38,741
+4,515
+13% +$146K ﹤0.01% 4051
2019
Q1
$1M Sell
34,226
-257,932
-88% -$7.31M ﹤0.01% 4113
2018
Q4
$7.51M Buy
292,158
+176,129
+152% +$6.1M ﹤0.01% 2434
2018
Q3
$4.08M Sell
116,029
-9,349
-7% -$373K ﹤0.01% 3388
2018
Q2
$5.13M Sell
125,378
-369,798
-75% -$14.9M ﹤0.01% 3111
2018
Q1
$19.4M Buy
495,176
+300,540
+154% +$11M 0.01% 1683
2017
Q4
$6.35M Sell
194,636
-62,500
-24% -$2.17M ﹤0.01% 2831
2017
Q3
$12.3M Buy
257,136
+82,525
+47% +$4.02M ﹤0.01% 2070
2017
Q2
$8.62M Buy
174,611
+144,432
+479% +$6.4M ﹤0.01% 2314
2017
Q1
$1.32M Sell
30,179
-2,817
-9% -$114K ﹤0.01% 4175
2016
Q4
$1.09M Sell
32,996
-20,420
-38% -$792K ﹤0.01% 4398
2016
Q3
$2.65M Buy
53,416
+25,097
+89% +$1.31M ﹤0.01% 3261
2016
Q2
$1.57M Sell
28,319
-15,786
-36% -$923K ﹤0.01% 3622
2016
Q1
$2.43M Buy
44,105
+3,064
+7% +$175K ﹤0.01% 3190
2015
Q4
$2.56M Sell
41,041
-187,183
-82% -$12.2M ﹤0.01% 3278
2015
Q3
$15.1M Buy
228,224
+97,016
+74% +$7.46M 0.01% 1611
2015
Q2
$10.3M Buy
131,208
+94,534
+258% +$6.8M ﹤0.01% 2085
2015
Q1
$2.63M Buy
36,674
+18,823
+105% +$1.21M ﹤0.01% 3332
2014
Q4
$1.09M Sell
17,851
-2,917
-14% -$170K ﹤0.01% 4084
2014
Q3
$1.01M Buy
20,768
+3,951
+23% +$193K ﹤0.01% 4022
2014
Q2
$766K Buy
16,817
+4,637
+38% +$204K ﹤0.01% 4271
2014
Q1
$550K Sell
12,180
-5,980
-33% -$295K ﹤0.01% 4479
2013
Q4
$859K Buy
18,160
+1,207
+7% +$52.4K ﹤0.01% 4048
2013
Q3
$669K Buy
16,953
+1,075
+7% +$39.9K ﹤0.01% 4124
2013
Q2
$526K Buy
+15,878
New +$515K ﹤0.01% 4218

Other funds holding ACHC

Morgan Stanley's ACHC Position: Q1 2026 in Review

Morgan Stanley increased its Acadia Healthcare (ACHC) stake by 194% in Q1 2026, buying an estimated $53.6M and bringing the position to 4,491,067 shares worth $105M. The position accounts for 0.01% of the portfolio, ranked #1401.

Morgan Stanley first reported a position in ACHC in Q2 2013 and has held it in 52 quarters since. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.

  • Morgan Stanley held 4,491,067 shares of Acadia Healthcare worth $105M as of Q1 2026.
  • Morgan Stanley bought 2,962,591 Acadia Healthcare shares in Q1 2026, an estimated $53.6M.
  • Acadia Healthcare made up 0.01% of Morgan Stanley's portfolio in Q1 2026, its #1401 holding.
  • Morgan Stanley first reported a position in Acadia Healthcare in Q2 2013 and has held it in 52 quarters since.
  • 295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.